| Term 
 | Definition 
 
        | *Renal fcn (BUN/Cr)-baseline then q2-3mo x 6mo, then q6-12mo *Preg test at baseline *Thyroid fcn-baseline then 1-2times x 6mo, then q6-12mo once dose is stabilized *ECG if >40y/o-baseline |  | 
        |  | 
        
        | Term 
 
        | 2nd gen antipsychotics monitoring |  | Definition 
 
        | *wt checks/BMI calc-baseline then q1mo x 3mo, then q3mo *FLP/FBG/HgbA1c-baseline, at 3mo, then qyr |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *WBC qwk x6mo then q2wks x6mo, then qwk indefinitely |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *BP and pulse *Sx's of depression, aggression or hostility *Growth rate in kids *signs of CNS stimulation *Routine ECG's and ECHO if pre-existing heart dz |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *BP and pulse *Pt growth *Attn, hyperactivity and anxiety *Worsening of aggressive behavior or hostility |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *CBC with diff *Lipid panel *CMP (Na, BUN/Cr, LFTs) *Ca2+ and Vit D (>6mo tx)->DEXA *UA *TFTs *Preg test |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Serum Na esp in the first 3mo of therapy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *VS if given IV b/c Fosphey is a Class IB anti-arrhythmic *CBC *LFTs *Ca2+ and Vit D (>6mo tx)->monitor DEXA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *ECG at baseline in pts with conduction problems or severe cardiac dz |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *BUN/Cr *Serum [HCO3]-baseline then q2-4mo |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | *CBC *LFTs *Ca2+ and Vit D (>6mo tx)->DEXA |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | *LFTs *CBC *Serum ammonia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *BMP (lytes, BUN/Cr) *Serum [HCO3]-baseline then q2-4mo |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *CBC-baseline then q1-2mo *LFTs-baseline then q1-2mo |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Psych effects (suicidal thoughts and depression) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *H&H and RBC indices-baseline then qyr *Vit B12-q2-3yrs *SCr-baseline then qyr |  | 
        |  | 
        
        | Term 
 
        | Bisphosphonate monitoring |  | Definition 
 
        | *Reeval in 1mo to assess tolerance *consider measurements of bone-turnover markers at 3 and 6mo *BMD with DEXA-at 1yr then twice a yr |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *TSH-after 6-8wks *TFTs-after 4-6wks fo tx (when euthyroid do it q6-12mo) *If central hypothyroidism then monitor [FT4] |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Some clinical resolution of thyrotoxicosis w/in 2wks *TSH and FT4-q4-6wks until stabilized |  | 
        |  | 
        
        | Term 
 
        | Management of Thyroid dz in pregnancy |  | Definition 
 
        | *monitor TSH q4wks during the 1st half of preg *Then, once at 26-32wks (Want TSH <2.5 in 1st trimester;<3.0 in the 2nd and 3rd) *Post-partum: resume pre-preg dose and check TSH in 6wks |  | 
        |  |